5‑Amino 1MQ 50 mg
€ 429,00
5‑Amino 1MQ 50 mg – ≥99% pure compound studied for NNMT inhibition, fat loss, energy metabolism, and NAD+ support. For research use only.
Not in stock but available within two weeks.
Includes bacteriostatic water, alcohol pads, mixing syringe and insulin syringes – everything you need for easy research preparation.
5‑Amino 1MQ 50 mg – Peptide for Metabolic and Fat Loss Research
5‑Amino 1MQ is a small‑molecule compound that has been studied for its ability to inhibit the enzyme NNMT (nicotinamide N‑methyltransferase). By blocking NNMT, 5‑Amino 1MQ may help increase NAD+ levels and enhance cellular metabolism. In research models, this mechanism has been linked to reduced fat cell size, improved energy expenditure, and potential metabolic benefits. At a strength of 50 mg, 5‑Amino 1MQ is commonly used in studies exploring fat loss, metabolic health, and age‑related conditions.Key Benefits
- ≥ 99% purity, verified by third‑party lab testing
- Studied for NNMT inhibition and increased NAD+ levels
- Researched for fat loss, energy metabolism, and healthy aging
- May support studies on obesity and metabolic disorders
- Highly stable and bioactive for consistent laboratory use
- For scientific and educational use only
⚠️ For Research Use Only! This product is not intended for human consumption, cosmetic, or medical use. It is strictly for laboratory and scientific research purposes only. Always handle according to applicable safety standards.
Key Benefits
- ≥ 99% purity, verified by third‑party lab testing
- Studied for NNMT inhibition and increased NAD+ levels
- Researched for fat loss, energy metabolism, and healthy aging
- May support studies on obesity and metabolic disorders
- Highly stable and bioactive for consistent laboratory use
- For scientific and educational use only
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.